Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.39% | $23.06M | €401.77B | 41.34% | 76 Outperform | |
| Roche Holding AG | 2.11% | $14.38M | CHF270.15B | 45.02% | 73 Outperform | |
| AstraZeneca | 2.11% | $14.36M | £220.54B | 29.01% | 80 Outperform | |
| HSBC Holdings | 1.96% | $13.35M | £204.52B | 48.96% | 80 Outperform | |
| Novartis AG | 1.93% | $13.10M | CHF216.20B | 24.14% | 80 Outperform | |
| SAP SE | 1.81% | $12.28M | €237.28B | -15.64% | 66 Neutral | |
| Nestlé SA | 1.71% | $11.64M | CHF188.36B | 12.31% | 71 Outperform | |
| Siemens | 1.61% | $10.99M | €199.94B | 30.63% | 74 Outperform | |
| Shell (UK) | 1.47% | $9.97M | £151.07B | -1.97% | 73 Outperform | |
| ― | 1.31% | $8.91M | ― | ― | ― |